Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,819
Closed -$214K – 654
2022
Q2
$214K Buy
+2,819
New +$214K 0.01% 525
2020
Q3
– Sell
-254
Closed -$26K – 494
2020
Q2
$26K Buy
254
+24
+10% +$2.31K ﹤0.01% 338
2020
Q1
$17K Buy
230
+211
+1,111% +$15.9K ﹤0.01% 290
2019
Q4
$2K Sell
19
-27
-59% -$2.31K ﹤0.01% 534
2019
Q3
$3K Buy
46
+40
+667% +$3.23K ﹤0.01% 610
2019
Q2
$1K Buy
+6
New +$482 ﹤0.01% 703
2018
Q1
– Sell
-37
Closed -$4K – 274
2017
Q4
$4K Hold
37
– – ﹤0.01% 540
2017
Q3
$4K Sell
37
-15
-29% -$1.9K ﹤0.01% 537
2017
Q2
$7K Hold
52
– – ﹤0.01% 470
2017
Q1
$7K Hold
52
– – ﹤0.01% 447
2016
Q4
$5K Buy
+52
New +$5.07K ﹤0.01% 449
2016
Q1
– Sell
-208
Closed -$23K – 363
2015
Q4
$23K Hold
208
– – ﹤0.01% 240
2015
Q3
$23K Hold
208
– – ﹤0.01% 268
2015
Q2
$22K Buy
208
+95
+84% +$9.83K ﹤0.01% 253
2015
Q1
$10K Buy
+113
New +$9.34K ﹤0.01% 297

Other funds holding INCY

Balentine LLC's INCY Position: Q3 2022 in Review

Balentine LLC sold out of Incyte (INCY) in Q3 2022, closing a stake of 2,819 shares — an estimated $214K sold.

Balentine LLC first reported a position in INCY in Q1 2015 and held it in 15 quarters. The position peaked at $214K in Q2 2022. 537 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

  • Balentine LLC reported no remaining Incyte position as of Q3 2022 after selling out during the quarter.
  • Balentine LLC sold 2,819 Incyte shares in Q3 2022, an estimated $214K.
  • Balentine LLC first reported a position in Incyte in Q1 2015 and held it in 15 quarters.
  • Balentine LLC's Incyte position peaked at $214K in Q2 2022.
  • 537 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.